期刊
REPRODUCTIVE SCIENCES
卷 29, 期 3, 页码 896-903出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s43032-021-00772-3
关键词
Fetal growth restriction; Confined placental mosaicism; Noninvasive assessment; Cell-free DNA in maternal plasma
资金
- JSPS KAKENHI [JP17K16870, JP20K09653]
CFDNA analysis in maternal plasma can screen for CPM, accounting for approximately 10% of the causes of moderate or severe FGR, with a higher proportion of abnormal karyotype cells in the placenta associated with more severe placental dysfunction and FGR.
We examined the influence of confined placental mosaicism (CPM) as a cause of fetal growth restriction (FGR), and whether CPM can be screened using cell-free DNA (cfDNA) analysis of the maternal plasma. We analyzed cfDNA in the maternal plasma of 40 FGR cases with an estimated fetal weight of less than - 2.0 SD using massively parallel sequencing to detect chromosomal aberrations. Fetal and placental genotyping was performed to confirm CPM cases. cfDNA analyses of maternal plasma detected suspected CPM cases with chromosomal aneuploidy or copy number variations in 5 of 40 cases (12.5%). For 4 cases in which the entire placenta consisted of cells with chromosomal abnormalities, fetal growth was severely restricted. CPM can be screened by cfDNA analysis in maternal plasma, accounting for approximately 10% of the causes of moderate or severe FGR, and the higher the proportion of abnormal karyotype cells in the placenta, the more severe the placental dysfunction and FGR.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据